Shareholder Vote

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549  _______________ FORM 8-K/A Amendment No. 1 CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934  _______________ Date of Report: May 4, 2017 (Date of earliest event reported)  _______________ TENET HEALTHCARE CORPORATION (Exact name of Registrant as specified in its charter)             Nevada   1-7293   95-2557091 (State of Incorporation)   (Commission File Number)   (IRS Employer Identification Number) 1445 Ross Avenue, Suite 1400 Dallas, Texas 75202 (Address of principal executive offices, including zip code) (469) 893-2200 (Registrant’s telephone number, including area code)   Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the Registrant under any of the following provisions: ¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) ¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) ¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) ¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))   Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).   Emerging Growth Company ¨   If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards pursuant to Section 13(a) of the Exchange Act. ¨   Item 5.07. Submission of Matters to a Vote of Security Holders. As previously reported on a Form 8-K filed on May 5, 2017, at the 2017 annual meeting of shareholders of Tenet Healthcare Corporation (the "Company"), the Company's shareholders approved, on an advisory basis, that future advisory votes on executive compensation be held annually. Pursuant to paragraph (d) of Item 5.07, this amendment to the previously-filed Form 8-K is being filed to report that, consistent with the results of the advisory vote, the Company's Board of Directors, acting through its Nominating and Corporate Governance Committee, determined on August 9, 2017 to continue holding an annual advisory vote with respect to the Company's executive compensation. The next required advisory vote on the frequency of shareholder votes on executive compensation will occur at the Company's 2023 annual meeting of shareholders. SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.       TENET HEALTHCARE CORPORATION     By:    /s/ Paul A. Castanon      Paul A. Castanon      Vice President, Deputy General Counsel and Corporate Secretary                     Date: August 11, 2017